Found: 9
Select item for more details and to access through your institution.
Anaplastic Features in Advanced Prostate Cancer With and Without DNA Damage Repair Mutations.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 6, p. e352, doi. 10.1016/j.clgc.2021.05.005
- By:
- Publication type:
- Article
A Case Report of Sequential Use of a Yeast-CEA Therapeutic Cancer Vaccine and Anti-PD-L1 Inhibitor in Metastatic Medullary Thyroid Cancer.
- Published in:
- Frontiers in Endocrinology, 2020, v. 11, p. N.PAG, doi. 10.3389/fendo.2020.00490
- By:
- Publication type:
- Article
Predicting clinical outcomes in chordoma patients receiving immunotherapy: a comparison between volumetric segmentation and RECIST.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer.
- Published in:
- BJU International, 2021, v. 127, n. 4, p. 435, doi. 10.1111/bju.15227
- By:
- Publication type:
- Article
Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 4, p. 364, doi. 10.1093/oncolo/oyac244
- By:
- Publication type:
- Article
Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2022, v. 27, n. 3, p. 198, doi. 10.1093/oncolo/oyab046
- By:
- Publication type:
- Article
Randomized, Double‐Blind, Placebo‐Controlled Phase II Study of Yeast‐Brachyury Vaccine (GI‐6301) in Combination with Standard‐of‐Care Radiotherapy in Locally Advanced, Unresectable Chordoma.
- Published in:
- Oncologist, 2021, v. 26, n. 5, p. e847, doi. 10.1002/onco.13720
- By:
- Publication type:
- Article
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid Tumors.
- Published in:
- Oncologist, 2020, v. 25, n. 7, p. 560, doi. 10.1634/theoncologist.2019-0932
- By:
- Publication type:
- Article
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 479, doi. 10.1634/theoncologist.2019-0608
- By:
- Publication type:
- Article